评估停用双膦酸盐有效性试验的可行性:一项先导研究
本研究为计划中的EDGE实用临床试验的先导研究,在长期使用阿仑膦酸钠的绝经后女性中评估工作流程与可行性。9个站点共招募27名参与者,行政程序总体可行且对门诊流程影响小,但参与者招募和治疗依从性欠佳,未报告骨折或不良事件。
要点
- 合同执行平均耗时3.4个月,机构审查委员会批准平均耗时13.9天。
- 共招募27名参与者,继续阿仑膦酸钠组13人,停用组14人。
- 22%的参与者未遵守随机分组,继续组为30.8%,停用组为14.3%。
核心结论
- EDGE研究的行政程序总体可行,对门诊流程影响最小。
- 在此便利样本中,多数实践站点的参与者招募欠佳。
- 考虑到治疗臂依从性低,需要全面的招募方法才能有效实现EDGE研究的科学目标。
研究设计与样本
- 为期6个月的先导研究,嵌套于计划中的EDGE实用临床试验。
- 研究对象为当前长期使用阿仑膦酸钠的女性,年龄≥65岁且阿仑膦酸钠使用≥3年。
- 评估内容包括行政方面(合同时间、机构审查委员会批准)、站点和参与者招募率、随机化后结局(依从性、双膦酸盐相关不良事件、参与者和站点满意度),在随机化后1个月和6个月评估结局。
- 共9个站点参与,包括7个社区医疗实践和2个学术医疗中心。
主要发现
- 合同执行平均耗时3.4个月(标准差2.3),机构审查委员会批准平均耗时13.9天(标准差4.1)。
- 站点共招募27名参与者,其中13人继续阿仑膦酸钠,14人停用阿仑膦酸钠。
- 随访期间22%的参与者未遵守随机分组,继续组为30.8%,停用组为14.3%。
- 未报告骨折或不良事件,站点未报告工作流程问题,参与者对研究高度满意。
局限性
- 在此便利样本中,参与者招募在多数实践站点欠佳。
- 治疗臂依从性低,22%的参与者未遵守随机分组。
- 需要全面的招募方法才能有效实现EDGE研究的科学目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The Effectiveness of Discontinuing Bisphosphonates (EDGE) study is a planned pragmatic clinical trial to guide "drug holiday" clinical decision making. This pilot study assessed work flow and feasibility of such a study. While participant recruitment and treatment adherence were suboptimal, administrative procedures were generally feasible and minimally disrupted clinic flow. INTRODUCTION: The comparative effectiveness of continuing or discontinuing long-term alendronate (ALN) on fractures is unknown. A large pragmatic ALN discontinuation study has potential to answer this question. METHODS: We conducted a 6-month pilot study of the planned the EDGE study among current long-term ALN users (women aged ≥65 with ≥3 years of ALN use) to determine study work flow and feasibility including evaluating the administrative aspects of trial conduct (e.g., time to contract, institutional review board (IRB) approval), assessing rates of site and participant recruitment, and evaluating post-randomization outcomes, including adherence, bisphosphonate-associated adverse events, and participant and site satisfaction. We assessed outcomes 1 and 6 months after randomization. RESULTS: Nine sites participated, including seven community-based medical practices and two academic medical centers. On average (SD), contract execution took 3.4 (2.3) months and IRB approval took 13.9 (4.1) days. Sites recruited 27 participants (13 to continue ALN and 14 to discontinue ALN). Over follow-up, 22% of participants did not adhere to their randomization assignment: 30.8% in the continuation arm and 14.3% in the discontinuation arm. No fractures or adverse events were reported. Sites reported no issues regarding work flow, and participants were highly satisfied with the study. CONCLUSIONS: Administrative procedures of the EDGE study were generally feasible, with minimal disruption to clinic flow. In this convenience sample, participant recruitment was suboptimal across most practice sites. Accounting for low treatment arm adherence, a comprehensive recruitment approach will be needed to effectively achieve the scientific goals of the EDGE study.
引用
- Wright NC, Foster PJ, Mudano AS, et al. Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study. Osteoporos Int. 2017. PMID: 28540506. doi:10.1007/s00198-017-4073-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。